Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Non-Current Liabilities (2018 - 2025)

Dna X (SONM) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $39.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities rose 21.51% year-over-year to $39.1 million, compared with a TTM value of $39.1 million through Sep 2025, up 21.51%, and an annual FY2024 reading of $43.7 million, up 36.06% over the prior year.
  • Total Non-Current Liabilities was $39.1 million for Q3 2025 at Dna X, up from $35.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $43.7 million in Q4 2024 and bottomed at $20.1 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $29.7 million, with a median of $29.7 million recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities fell 29.33% in 2024, then soared 68.02% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $21.1 million in 2021, then skyrocketed by 53.02% to $32.2 million in 2022, then fell by 0.2% to $32.1 million in 2023, then soared by 36.06% to $43.7 million in 2024, then decreased by 10.59% to $39.1 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for SONM at $39.1 million in Q3 2025, $35.7 million in Q2 2025, and $35.2 million in Q1 2025.